{
    "Symbol": "AMGN",
    "AssetType": "Common Stock",
    "Name": "Amgen Inc",
    "Description": "Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.",
    "CIK": "318154",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "125190668000",
    "EBITDA": "13486000000",
    "PERatio": "19.34",
    "PEGRatio": "1.55",
    "BookValue": "6.86",
    "DividendPerShare": "7.76",
    "DividendYield": "0.0363",
    "EPS": "12.12",
    "RevenuePerShareTTM": "48.93",
    "ProfitMargin": "0.249",
    "OperatingMarginTTM": "0.383",
    "ReturnOnAssetsTTM": "0.0997",
    "ReturnOnEquityTTM": "1.265",
    "RevenueTTM": "26322999000",
    "GrossProfitTTM": "19917000000",
    "DilutedEPSTTM": "12.12",
    "QuarterlyEarningsGrowthYOY": "-0.109",
    "QuarterlyRevenueGrowthYOY": "-0.001",
    "AnalystTargetPrice": "258.76",
    "TrailingPE": "19.34",
    "ForwardPE": "14.95",
    "PriceToSalesRatioTTM": "5.49",
    "PriceToBookRatio": "39.6",
    "EVToRevenue": "6.53",
    "EVToEBITDA": "13.85",
    "Beta": "0.633",
    "52WeekHigh": "292.06",
    "52WeekLow": "217.72",
    "50DayMovingAverage": "255.72",
    "200DayMovingAverage": "252.83",
    "SharesOutstanding": "533976000",
    "DividendDate": "2023-03-08",
    "ExDividendDate": "2023-02-14"
}